||EPS - Basic
||Market Cap (m)
|Technology Hardware & Equipment
Crimson Tide Share Discussion Threads
Showing 451 to 474 of 475 messages
|There are only 103 million shares available for daily trades and I believe most of them have been bought and kept by small investors like us.... small means holding under 500k of shares
I hope the break out above 4p will happen this month|
|A maiden dividend is required to support the share price sustainable higher, perhaps 0.001 pence per share|
|I like where this company is going !|
the shuffle man
|Today Ireland, tomorrow the World.
'We have multiple, early stage opportunities'|
|on the way to 5.5p|
|I see TIDE breaking out and 4p+ on the horizon.
good luck all.|
|start climbing up nicely|
|I think the business has a total value in excess £25m or over 5.5p per share considering the growth, etc.|
|Looks like we are going to break out to the upside. May be news in the offing ?|
the shuffle man
|Biggest daily trading volume in the last 4 weeks.|
|Is TIDE on the way to 4p+|
|Good to hear from you Jamielein. The fact you've considered the investment case... and parted with your hard earned, gives me reassurance.
Growth coupled with fantastic margins and a recurring revenue element drew my attention. The fact that they've concluded contracts with Nestle & other blue chips was the clincher.
|Ghf, good to see you here. It's been a while since we've had the same investment in common. I've been a lot less active recently due to a new job and fewer market opportunities in general.
I've been holding TIDE for some time. I like the growth prospects which will hopefully make their current multiple look a lot more reasonable in the future.|
|Courtesy to say I've been buying here over the last couple of months, although you wouldn't realise with the share price pull-back!!!
Also delighted with today's update which sets TIDE up nicely for 2017.
WH Ireland provide the following brief update on the back of today's t/s,
"...positive update from TIDE this morning confirming not only that trading in the current year to 31 December is in line with expectations but also signalling that it has already absorbed some of the costs of a step change in investment to grow a much larger business in 2017 and beyond.
For 2016, TIDE confirms revenue for the year is expected to total £1.8m (WHI £1.8m) whilst we look for a reported PBT of £0.4m, double the 2015 result. Staff count has also doubled in the past 18 months.
One key takeaway from today's update is that the rollout of the major supermarket contract has been completed ahead of forecast hence revenues are now being recognised on the whole estate. Whilst this will clearly have some minor benefit in 2016, it means TIDE starts 2017 at full pelt underpinning future investment plans.
This statement rounds off a hugely successful year for TIDE with three main contract wins/ extensions including a long-term tie up with the National Centre for Hereditary Disorders in Ireland (the first significant breakthrough into the Healthcare sector) and its largest ever multi-year contract signed with a UK supermarket in October.
TIDE is utilising this momentum to step up investment in growing a much bigger business, the size and scope of which should become clearer in the New Year when we expect to revisit our 2017 and 2018 forecasts."
|Going back to the pharmaceutical verification pilot, TIDE have many years of experience with scanning of bar codes on blood supplies, haemophilia patients in this country have been able to verify the safety of their medication via the mpro platform
I wonder if the work on the pilot was responsible for the additional functionality that has been added to the platform, as highlighted in the recent NCHCD contract.|
|I'm also happy to hold and will probably add. With their latest supermarket contract
(their largest contract to date) now fully rolled out to nearly 500 stores, ahead of schedule, they will have a full years revenue in next years numbers.
There is also an increased value contract extension with Interserve to add to that.
They are also talking about international expansion, what I am looking for here is news on their pharmaceutical verification pilot. They are 5 months into the pilot
now so hoping to hear about this in the not to distant. Sounds like it could be rolled out in several Asian countries if it goes ahead.
Positive outlook as well.
Barrie Whipp, Executive Chairman, commented "We have continued to win profitable, cash generative business with high levels of visible, recurring revenue from major organisations. These contracts provide a very stable platform from which to continue to grow the business but also excellent reference sites for attracting new customers, which is always a key challenge for smaller companies. Our team has doubled in number in 18 months and we expect our results to show a doubling of profits for the second year in a row. This gives us the resources and confidence for sound strategic investments which will enable us to drive the business forward aggressively in 2017 and beyond. The Board is very confident for the future"|
|Yes another good trading statement. The company is not cheap but is growing quickly. Happy to continue to hold.|
|I am already in, enjoy the ride hopefully.|
|Another great trading statement today with a very positive outlook. This is well under the radar. Wake up peeps.|
the shuffle man
|And up she goes !|
the shuffle man
|Looks like an overhang has been cleared. Hopefully the price will start moving up again.|
the shuffle man
|Hmmm what's going on here then. Huge buying all of a sudden.|
|Agreed there are a lot of poor/dubious companies on Aim.
However, it is my experience that if you pick a good one that is underpriced and meets some or all of my criteria, you can make money eg Eckoh, Tristel, Proactis, Airea and, I hope Crimson Tide|
|It's just my personal opinion but looking at companies with no debt, good cashflow and good visibility of forward earnings is a very sensible approach that would work on say FTSE 100 or FTSE 250 companies. However, AIM is a different animal. Those points don't necessarily correlate with share price performance. Trend Following, Momentum Investing or even Value Investing and different strategies that could help make money on AIM shares but Value Investing would be extremely difficult as 90% of companies on AIM are utter rubbish.|